Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Deucravacitinib Impurity6
Deucravacitinib Impurity6
  • Deucravacitinib Impurity6
  • Deucravacitinib Impurity6
  • Deucravacitinib Impurity6
  • Deucravacitinib Impurity6
  • Deucravacitinib Impurity6

Deucravacitinib Impurity6 NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-07-31

Product Details

Product Name: Deucravacitinib Impurity6 CAS No.: 1609393-48-7
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/07/31
Molecular formula: C19H17D3N8O3

Deucravacitinib Impurity6;1609393-48-7

Article illustration

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

Product Information

  • Product Code:D084006

  • English Name:Deucravacitinib Impurity 6

  • English Alias:6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide

  • CAS No.:1609393-48-7

  • Molecular Formula:C₁₉H₁₇D₃N₈O₃

  • Molecular Weight:411.43

Advantages

  • High-Purity Isotopic Standard:Confirmed by HPLC (≥99.0%), NMR (1H, 13C, DEPT), HRMS (isotope peak analysis), and elemental analysis, with ≥99% deuterium labeling (methyl-d3), providing an accurate isotopic internal standard for Deucravacitinib impurity analysis.

Background Description

Deucravacitinib, a selective tyrosine kinase 2 (TYK2) inhibitor, is used for treating autoimmune diseases such as psoriasis by regulating intracellular signaling pathways and inhibiting inflammatory responses. Impurity 10, a process-related impurity in its synthesis, may originate from side reactions during cyclopropane acylation, triazole ring construction, or subsequent condensation reactions. Its cyclopropane amide group, methoxy group, triazole ring, and carboxylic acid group may affect the drug's metabolic stability, lipophilicity, and binding ability to the target. Since drugs for treating autoimmune diseases are taken long-term, strict control of impurities is crucial for patient safety, making research on this impurity an important part of ensuring drug quality.

Research Status

  • Detection Technology:UPLC-MS/MS technology, combined with a C18 column (1.7μm) and gradient elution with 0.1% formic acid - acetonitrile, achieves impurity separation within 8 minutes, with a detection limit as low as 0.003 ng/mL for high-precision trace impurity detection.

  • Formation Mechanism:Formed by the acylation reaction of 4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylic acid with cyclopropanecarbonyl chloride under the action of an alkaline catalyst (such as triethylamine). Optimizing the dosage of the catalyst and the reaction pH can effectively inhibit side reactions.

  • Safety Evaluation:In vitro cytotoxicity experiments show that the IC₅₀ of this impurity against HaCaT cells is 186.3 μM (Deucravacitinib IC₅₀ = 7.2 μM). Although the toxicity is lower than that of the main drug, its content in drugs still needs to be strictly controlled. Currently, long-term stability tests are being carried out to systematically study its degradation characteristics and potential risks under high temperature, high humidity, and light conditions.





NOTE!

We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com


NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 






Company Profile Introduction

-

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/1g
VIP2Y
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
2024-07-03
$0.00/10g
Cangzhou Kangrui Pharma Tech Co. Ltd.,
2024-12-02
$61.00/1mg
VIP4Y
TargetMol Chemicals Inc.
2025-11-10
INQUIRY